Seigneurs D’aiguilhe Castillon Bordeaux

This is the second wine from Château d’Aiguilhe, in the far east of Bordeaux. Proprietor and winemaker Stephan von Neipperg is also responsible for the greatness that lies in each bottle of Château Canon-La-Gaffelière, Clos l’Oratoire, Château Peyreau and La Mondotte.

The cepage is overwhelmingly Merlot, with a small percentage of Cabernet Franc. The property dates back to the 12th century and is linked to the Knights Templar. The current château, a “fortified farmhouse,” was built in the 13th century. The Right Bank terroir, with its clay-limestone soils, produce outstanding Merlot and Cabernet Franc grapes.

Five First Growths of Bordeaux

A tasty great investment

The Exposition Universelle of 1855, held in Paris, attracted millions of visitors, who passed through grand halls where the latest works of industry and culture were on display. In the 19th century, France was recognized as the world’s finest producer of wine — so there was no question that wines would be offered for sampling. The question was how thewines would be exhibited.

 Bordeaux’s wines (commonly referred to as clarets) were already known around the world, particularly in England, whose wealthier classes had been importing them in mass quantities for centuries. So, it was no surprise that the country’s new Emperor, Napoleon III, ordered a classification drawn up of Bordeaux’s best wines. The wines were ranked by reputation and price, with an emphasis on the latter. The result was The Bordeaux Wine Official Classification of 1855.

Chateau Cheval Blanc

Château Cheval Blanc (French for “White Horse Castle”), is a wine producer in Saint-Émilion in the Bordeaux wine region of France. As of 2012, its wine is one of only four to receive the highest rank of Premier Grand Cru Classé (A) status in the Classification of Saint-Émilion wine, along with Château Angélus, Château Ausone, and Château Pavie.

Phizer Inc. ~ 12-03-2021

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare.

Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.